Mon. 13 May 2024, 4:07pm ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Biolase (NASDAQ:BIOL) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.17) by 111.76 percent. The company reported quarterly sales of $10.131 million which beat the analyst consensus estimate of $9.996 million by 1.35 percent. This is a 3.21 percent decrease over sales of $10.467 million the same period last year.